urothelial carcinoma: maintenance therapies
Published 4 years ago • 57 plays • Length 3:48Download video MP4
Download video MP3
Similar videos
-
1:02
maintenance therapy in urothelial carcinoma
-
0:50
maintenance therapy for patients with advanced urothelial carcinoma
-
1:11
maintenance therapy for bladder cancer
-
1:59
study design of uro-12 trial of niraparib as maintenance therapy for advanced urothelial carcinoma
-
2:41
results from uro-12 trial of niraparib maintenance therapy for advanced urothelial carcinoma
-
3:37
optimal treatment strategies for patients with metastatic urothelial carcinoma
-
4:34
optimising treatment for advanced urothelial cancer: combination, maintenance or sequencing?
-
0:42
targeted therapies in metastatic urothelial carcinoma
-
5:31
javelin bladder 100: avelumab maintenance
-
1:23
recent advances in the use of targeted therapies for metastatic urothelial carcinoma
-
2:50
avelumab maintenance for urothelial cancer
-
1:17
recent advances in the treatment of upper tract urothelial carcinoma
-
2:35
urothelial carcinoma treatment: the future
-
3:05
javelin bladder 100: 1l urothelial cancer updates
-
4:00
overview of urothelial carcinoma treatment landscape – the promise of immunotherapy
-
2:06
main-cav: maintenance cabozantinib and avelumab in urothelial cancer
-
2:05
the evolving treatment landscape of advanced and metastatic urothelial carcinoma
-
4:49
advanced upper urinary tract urothelial carcinoma: treatment landscape and remaining challenges
-
1:12
javelin bladder 100: avelumab maintenance for metastatic or locally advanced bladder cancer